← Home / Prestige Consumer Healthcare Inc. (PBH)
Stock Analysis
Prestige Consumer Healthcare Inc. (PBH)
PBH
PBH · Market data
50.22 +0.54%
Track PBH in your personal workspace Monitor performance, SPY relative strength and WOI View from your watchlist.
Alert me when PBH price is:
52W Range Position
16%
LOWMIDHIGH
Trend
Mixed
Momentum
Neutral
Updated: 2026-08-02 18:35 UTC
WOI Investment Thesis
Mixed
Confirmation improves above 57.39. Holding above 49.89 keeps the current thesis intact.
⚖️
✓
Fundamentals
Weak / Strong
✓
Price Structure
Mixed
•
Momentum
Neutral
×
Breakout Confirmation
Pending
Risk Level
Elevated
Analysis Scope
1Y Daily
Key Decision Levels
✓
Hold Above
Structure remains valid above support.
49.89
↗
Break Above
Confirmation improves above resistance.
57.39
🎯
Next Objective
Pattern-derived target if setup continues.
—
×
Thesis Break
Scenario weakens below invalidation.
Below 49.89
Recent Company Events
SEC VERIFIED
Latest material filings
JUL
15
$
Debt Financing
HIGH
PBH debt financing update
On July 15, 2026, Prestige Brands, Inc.
8-K Filing • SEC EDGAR
JUL
6
$
Debt Financing
HIGH
Prestige Consumer Healthcare Inc Completes Acquisition of LaCorium Health, Prices $400 Million Senior Notes Offering, and Announces First Quarter Fiscal 2027 Earnings Results Date
(NYSE:PBH) (“Prestige”) today announced that it has closed the previously announced acquisition of LaCorium Health (“LaCorium”), priced a private offering of $400 million in senior notes, and will report its first quarter fiscal 2027 results on August 6, 2026.
8-K Filing • SEC EDGAR
JUN
16
$
Debt Financing
HIGH
PBH debt financing update
New Term Loan Facility On June 12, 2026 (the “Closing Date”), Prestige Consumer Healthcare Inc.
8-K Filing • SEC EDGAR
What's Driving PBH?
📈 Technical recovery is improving
Momentum is Neutral. Watch 57.39 for confirmation and 49.89 for structure risk.
💼 Business quality remains relevant
Fundamentals remain relevant. Check growth, profitability, cash flow and balance sheet quality.
⚠️ Key risk remains
Below 49.89
Full Analysis Workspace
Technical Signal
Waiting for Confirmation
▲
No confirmed breakout yet. Watch the next level and momentum behavior.
RSI(14)
53.1
◎
How to read this setup
The nearest decision zone is framed by support around 49.89 and resistance near 57.39. A cleaner push through resistance would improve continuation odds, while a loss of support would weaken the current thesis.
Price Chart
PBH — 1D Chart
Open Full Workspace
Valuation Snapshot (TTM)
Full valuation · Ratios use trailing twelve months
Updated 2026-07-31
Value
Value-oriented setup
Low multiples and positive free cash flow suggest a more grounded valuation.
Market Cap
$2.4B
Company size
EV
$3.4B
Debt-adjusted value
P/E
12.9
Low multiple
P/S
2.2
Low sales multiple
P/B
1.3
Low book multiple
EV/Sales
3.1
Low sales multiple
EV/EBIT
11.0
Low multiple
P/FCF
9.9
Low multiple
FCF Yield
10.07%
Cash return
Source: SEC TTM data via WOI valuation cache Not financial advice
Business Lens
High-quality business, softer growth
Financial quality is mixed, with cash flow or balance sheet items requiring closer monitoring.
↗
Revenue Growth
Weak
●
Profitability
Strong
≈
Cash Flow
Positive
⚖
Balance Sheet
Manageable
💵 Revenue
283.44M
↘ Weak
📈 Net Income
190.30M
↗ Strong
🧮 EPS (Basic)
0.98
↗ Strong
Prestige Consumer Healthcare Inc.
Related Opportunities